Morgan Stanley discloses 7.5% stake in Zepp Health

Zepp Health Corp Schedule 13G filing reports that Morgan Stanley (through reporting units) beneficially holds 8,472,224 Class A Ordinary Shares / ADRs, representing 7.5% of the class.

Rhea-AI Filing Summary

Zepp Health Corp Schedule 13G filing reports that Morgan Stanley (through reporting units) beneficially holds 8,472,224 Class A Ordinary Shares / ADRs, representing 7.5% of the class. The filing lists shared voting power of 8,472,128 and shared dispositive power of 8,472,224, and is signed by an authorized Morgan Stanley signatory.

Insights

Institutional Ownership Specialist

Morgan Stanley reports a meaningful passive holding of 7.5% in Zepp Health.

The filing is a routine Schedule 13G disclosure that lists beneficial ownership of 8,472,224 shares and corresponding shared voting and dispositive powers. Schedule 13G typically signals a passive investor position rather than an activist intent.

Key dependencies include whether holdings change in subsequent filings and any shifts to a Schedule 13D; future filings will show if the stake remains passive or becomes active.

Key Figures

Beneficial ownership: 8,472,224 shares Percent of class: 7.5% Shared voting power: 8,472,128 shares +2 more

5 metrics

Beneficial ownership 8,472,224 shares Class A Ordinary Shares / ADRs

Percent of class 7.5% Percentage of Class A Ordinary Shares reported

Shared voting power 8,472,128 shares Shared power to vote as reported on cover page

Shared dispositive power 8,472,224 shares Shared power to dispose as reported on cover page

CUSIP 98945L204 Class A Ordinary Shares / ADRs identifier

Key Terms

Schedule 13G, Beneficially owned, Shared dispositive power, Shared voting power

4 terms

Schedule 13G regulatory

"Item 1. | (a) | Name of issuer: Zepp Health Corp"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: See the response(s) to Item 9"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Shared dispositive power financial

"7 | Shared Dispositive Power 8,472,224.00"

Shared voting power financial

"6 | Shared Voting Power 8,472,128.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Morgan Stanley report in Zepp Health (ZEPP)?

Morgan Stanley reports beneficial ownership of 8,472,224 shares (7.5%). The Schedule 13G lists shared voting power of 8,472,128 and shared dispositive power of 8,472,224, filed and signed as a passive reporting submission.

Does the Schedule 13G indicate Morgan Stanley plans to take control of ZEPP?

No, the filing is a Schedule 13G passive disclosure indicating a passive stake. It reports holdings and shared powers but does not state any intent to influence management or seek control.

Which class of Zepp Health shares are reported in the filing?

The filing covers Class A Ordinary Shares / American Depositary Receipts for Zepp Health (CUSIP 98945L204), as stated in Item 2(d) of the Schedule 13G cover information.

Who signed the Schedule 13G for Morgan Stanley and when?

An authorized signatory, Claire Gordon, signed the filing on the cover page; the signature block shows the date 06/26/2026 associated with the submission.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 05:01 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Zepp Health Corp

(Name of Issuer)

Class A Ordinary Shares / American Depositary Receipts

(Title of Class of Securities)

98945L204

(CUSIP Number)

09/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 98945L204

1

Names of Reporting Persons

Morgan Stanley

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 8,472,128.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 8,472,224.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

8,472,224.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.5 %

12

Type of Reporting Person (See Instructions)

HC, CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Zepp Health Corp
(b)	Address of issuer's principal executive offices: BUILDING B2, ZHONG'AN CHUANGGU, TECHNOLOGY PARK NO.900 WANGJIANG WEST RD, HEFEI, F4, 230088
Item 2.
(a)	Name of person filing: Morgan Stanley
(b)	Address or principal business office or, if none, residence: 1585 Broadway, New York, NY 10036
(c)	Citizenship: Delaware
(d)	Title of class of securities: Class A Ordinary Shares / American Depositary Receipts
(e)	CUSIP Number(s): 98945L204
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s).
(b)	Percent of class: 7.5 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s).
	(ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s).
	(iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s).
	(iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s).
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. * In Accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Morgan Stanley

Signature:	Claire Gordon
Name/Title:	Authorized Signatory, Morgan Stanley
Date:	06/26/2026